The Enterprise Value as of December 2025 (TTM) for Pharmala Biotech Holdings Inc. (MDMA.CN) is 11.44M

According to Pharmala Biotech Holdings Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.44M. This represents a change of -23.59% compared to the average of 14.98M of the last 4 quarters.

Pharmala Biotech Holdings Inc. (MDMA.CN) Historical Enterprise Value (quarterly & annually)

How has MDMA.CN Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharmala Biotech Holdings Inc. over the last ten years is 8.31M. The current 11.44M Enterprise Value has changed 13.67% with respect to the historical average. Over the past ten years (40 quarters), MDMA.CN's Enterprise Value was at its highest in in the May 2023 quarter at 27.31M. The Enterprise Value was at its lowest in in the May 2021 quarter at 0.

Pharmala Biotech Holdings Inc. (MDMA.CN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharmala Biotech Holdings Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pharmala Biotech Holdings Inc. (MDMA.CN) Average Enterprise Value

How has MDMA.CN Enterprise Value performed in the past?

The current Enterprise Value of Pharmala Biotech Holdings Inc. (MDMA.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pharmala Biotech Holdings Inc. (MDMA.CN) Enterprise Value vs. Peers

How is MDMA.CN’s Enterprise Value compared to its peers?

Pharmala Biotech Holdings Inc.’s Enterprise Value is greater than Marvel Biosciences Corp. (11.17M), greater than PharmaTher Holdings Ltd. (9.07M), greater than BetterLife Pharma Inc. (8.88M), greater than Red Light Holland Corp. (637.69K), greater than Medicure Inc. (7.94M), less than Hemostemix Inc. (19.96M), greater than Comprehensive Healthcare Systems, Inc. (8.71M), greater than Glow Lifetech Corp. (9.28M), less than Britannia Life Sciences Inc. (16.15M), less than PreveCeutical Medical Inc. (16.23M),

Build a custom stock screener for Pharmala Biotech Holdings Inc. (MDMA.CN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmala Biotech Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmala Biotech Holdings Inc. (MDMA.CN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmala Biotech Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.